Physician profile
Roy C Terry
NPI 1649271206
$3,274.96
in general payments reported to CMS, 2019-2025
33 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $351 · 2021: $575 · 2022: $370 · 2023: $731 · 2024: $565 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $516.68 | 2019-2025 | Euflexxa |
| Amgen INC. | $476.98 | 2019-2025 | Evenity, Prolia |
| Radius Health, INC. | $308.80 | 2019-2024 | Tymlos |
| Stryker Corporation | $231.17 | 2021-2024 | Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $157.43 | 2019-2024 | Redapt, Stravix, Legion Revision |
| Depuy Synthes Sales INC. | $150.13 | 2019-2025 | Monovisc, Orthovisc, Fibulink |
| Organogenesis INC. | $148.56 | 2023 | Puraply, Affinity |
| Djo, LLC | $137.44 | 2021-2024 | Cmf |
| Skeletal Dynamics INC | $120.00 | 2021-2024 | Ijs, Geminus, Align |
| Pacira Therapeutics, INC. | $111.76 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $111.66 | 2020-2025 | Exparel, Zilretta, Iovera |
| Endo Pharmaceuticals INC. | $111.65 | 2019-2023 | Xiaflex |
| Orthofix Medical, INC. | $83.72 | 2019-2024 | Physio-Stim |
| Sanara Medtech INC. | $77.46 | 2021-2023 | Celleraterx |
| Orthogenrx INC. | $64.70 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $44.55 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Zimmer Biomet Holdings, INC. | $38.91 | 2020-2024 | Gel-One Cross-Linked Hyaluronate |
| Endo USA, INC. | $38.04 | 2025 | Xiaflex |
| Sanofi-Aventis U.S. LLC | $34.55 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $34.08 | 2020-2021 | |
| Medical Device Business Services, INC. | $31.55 | 2023 | Fms Duo |
| Horizon Therapeutics Plc | $29.18 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $25.69 | 2020 | |
| Acera Surgical, INC. | $23.17 | 2025 | Restrata Wound Matrix |
| Protega Pharmaceutials INC | $22.59 | 2025 | Roxybond |
| Kerecis Limited | $21.15 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Electronic Waveform Lab, INC. | $19.55 | 2019 | |
| Mimedx Group, INC. | $19.28 | 2024 | |
| Arthrex, INC. | $18.84 | 2023 | Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Avanos Medical | $18.81 | 2022 | |
| Pfizer INC. | $17.25 | 2024 | |
| Grifols USA, LLC | $15.65 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.